Suspension of trading

Bellicum Pharmaceuticals, Inc. Stock

Stocks

BPXA

US0794814048

Biotechnology & Medical Research

OTC Markets Traded
Market Closed - 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Bellicum Pharmaceuticals, Inc. -2.31% -53.99%
3 years 0
Extreme 0
0.19
5 years 0
Extreme 0
0.19
10 years 0
Extreme 0
0.19
Manager TitleAgeSince
Chief Executive Officer 66 23/02/2024
Chief Executive Officer 57 31/01/2017
Director TitleAgeSince
Director/Board Member 57 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
22/11/23
Baker Bros. Advisors LP
OptionCompany 4,232,698 44.5721%
03/01/23 Exercice

Director

60,414 0.7014%
03/01/23 Exercice

Director

60,414 0.7014%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-2.31% - - 822K
-0.94%-0.71%+45.60%+103.25% 68.52B
-0.07%-3.93%+32.54%+78.50% 62.88B
+3.13%+1.71%-12.50%+390.48% 28.13B
-2.83%-6.51%+26.06%+11.01% 25.56B
-0.54%-5.47%-3.88%-18.31% 24.65B
-1.43%-1.89%+21.32%-19.01% 19.81B
-4.27%+3.07%+211.22%+362.48% 17.69B
-2.29%-5.43%-6.13%+501.54% 14.66B
+1.14%-0.34%+52.38%+163.82% 14.45B
Average -0.83%-1.70%+40.73%+174.86% 27.64B
Weighted average by Cap. -0.69%-1.87%+36.97%+139.61%

Financials

2021 2022
Net sales 6.2M 5.34M 5.02M 4.58M 8.56M 590M 8.6M 59.54M 23.01M 301M 23.28M 22.78M 952M 1.5M 1.29M 1.22M 1.11M 2.07M 143M 2.08M 14.4M 5.57M 72.72M 5.63M 5.51M 230M
Net income -9.7M -8.35M -7.86M -7.16M -13.41M -923M -13.46M -93.2M -36.02M -470M -36.44M -35.65M -1.49B -24.97M -21.49M -20.23M -18.44M -34.5M -2.38B -34.63M -240M -92.68M -1.21B -93.77M -91.74M -3.84B
Net Debt - -
Logo Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals Inc is a United States-based company. The Company operates as a biopharmaceutical company focused on discovering and developing cellular immunotherapies for various forms of cancer.
Employees
13
  1. Stock Market
  2. Stocks
  3. BPXA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!